Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9062088 | 0.72 | IDH1 (0.33) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL8168376 | 0.67 | IDH1 (0.30) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL2169311 | 0.67 | DAO (0.41) | — | |
| SCHEMBL3480363 | 0.67 | ALDH1A1 (0.38) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL633410 | 0.67 | CSNK2A2 (0.41) | CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL8935314 | 0.67 | IDH1 (0.30) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL9860156 | 0.65 | — | — | |
| SCHEMBL909537 | 0.65 | — | — | |
| SCHEMBL29202814 | 0.65 | DAO (0.39) | — | |
| SCHEMBL11716446 | 0.65 | CSNK2A2 (0.39) | CSNK2A2CSNK2BCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230205087-A1 | PHOTORESIST UNDERLAYER COMPOSITION | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2023-06-29 | — | — | US | disclosed |
| US-20220397827-A1 | COMPOSITION FOR PHOTORESIST UNDERLAYER | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-12-15 | — | — | US | disclosed |
| US-20210200093-A1 | COATING COMPOSITION FOR PHOTORESIST UNDERLAYER | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2021-07-01 | — | — | US | disclosed |
| US-20200133126-A1 | COATING COMPOSITION FOR FORMING RESIST UNDERLAYER FILM FOR EUV LITHOGRAPHY PROCESS | DUPONT SPECIALTY MATERIALS KOREA LTD (KR) | 2020-04-30 | — | — | US | disclosed |
| CN-103229110-A | Developer replenishing container, developer replenishing system, and image formation device | CANON KK | 2013-07-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200133126-A1 | COATING COMPOSITION FOR FORMING RESIST UNDERLAYER FILM FOR EUV LITHOGRAPHY PROCESS | ETV6, PRDM9, PARG | IDH1 4835/4885CSNK2A2 2549/4885CSNK2B 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.